Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting

J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e441-e442. doi: 10.1111/jdv.17178. Epub 2021 Mar 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Italy
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab